Literature DB >> 2956451

Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome.

T Tulassay, W Rascher, R E Lang, H W Seyberth, K Schärer.   

Abstract

Plasma levels of atrial natriuretic peptide (ANP), arginine vasopressin (AVP), renin activity (PRA), aldosterone (PA), catecholamines and urinary prostaglandins (PG), as well as renal function were measured in children in the edematous state of the nephrotic syndrome before and after infusion of human serum albumin. Before albumin infusion, plasma levels of AVP, PRA, PA and noradrenaline (NA) and urinary excretion of PGE2, PGE-Met, PGF2 alpha were elevated. The mean value of plasma ANP was in the normal range. Albumin infusion produced a 36% increase in the calculated plasma volume. It was associated with a fivefold rise in the plasma level of ANP (31.6 +/- 22.6 vs. 151.4 +/- 52 fmol/ml mean, SD), and a significant fall in the levels of PRA, AVP, PA, and NA. Similarly, urinary concentration of PGE2, PGE-Met and PGF2 alpha fell. Urine flow, GFR, UNaV, FENa, and COsm increased significantly, while CH2O remained unchanged. The diuresis, natriuresis and GFR correlated with the level of plasma ANP, while urinary sodium excretion did not correlate with PA or NA levels. These findings suggest that ANP plays an important role in albumin induced natriuresis in children with nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956451     DOI: 10.1038/ki.1987.154

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Underfill and overflow revisited: mechanisms of nephrotic edema.

Authors:  M H Humphreys; J P Valentin; C Qiu; W Z Ying; W P Muldowney; D G Gardner
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Atrial natriuretic peptide and blood volume during red cell transfusion in preterm infants.

Authors:  W Rascher; N Lingens; M Bald; O Linderkamp
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

3.  Role of the renal nerves in renal sodium retention and edema formation.

Authors:  G F DiBona
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

Review 4.  Intra- and extrarenal factors of oedema formation in the nephrotic syndrome.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

5.  Tolvaptan therapy for massive edema in a patient with nephrotic syndrome.

Authors:  Masaki Shimizu; Sayaka Ishikawa; Yusuke Yachi; Masahiro Muraoka; Yuko Tasaki; Hidenori Iwasaki; Mondo Kuroda; Kazuhide Ohta; Akihiro Yachie
Journal:  Pediatr Nephrol       Date:  2013-11-19       Impact factor: 3.714

6.  The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial.

Authors:  Motoko Kanzaki; Jun Wada; Yoko Kikumoto; Shigeru Akagi; Kazushi Nakao; Hitoshi Sugiyama; Hirofumi Makino
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-05

Review 7.  Human albumin infusion for treating oedema in people with nephrotic syndrome.

Authors:  Jacqueline J Ho; Azreen S Adnan; Yee Cheng Kueh; Nurul Jannah Ambak; Hans Van Rostenberghe; Fauziah Jummaat
Journal:  Cochrane Database Syst Rev       Date:  2019-07-12

8.  Changes of atrial natriuretic peptide level in patients with nephrotic syndrome after supine bicycle exercise.

Authors:  S K Park; H Lee; T S Park; H S Baek; S K Kang; G Y Koh; S H Kim; K W Cho
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.